NSCLC samples; paired adjacent normal tissue specimens; NSCLC tissue samples
16HBE; H1299; H1581; H358; A549
-
proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); ceRNA regulation (other)
RT-qPCR; Clinical Sample Validation; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Luciferase Reporter Assay; Western Blot; Bioinformatics Analysis; Cohort Study; Survival Analysis
High circ-RAD23B expression was associated with positive lymph node invasion, lower differentiation grade and shorter overall survival, and circ-RAD23B was proposed as a promising biomarker and therapeutic target for NSCLC.
circ-RAD23B is up-regulated in NSCLC tissues and cell lines and high expression is associated with lymph node invasion, lower differentiation grade and shorter overall survival. Functionally, it promotes NSCLC cell growth, migration and invasion while suppressing apoptosis. Mechanistically, it sponges miR-593e3p and miR-653e5p to increase CCND2 and TIAM1 expression, supporting its potential as a prognostic biomarker and therapeutic target.
0.7408
Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer.
combined biological and clinical study